Developing an Oncology Workforce for the 21st Century - Renewal 01

 描述(由申请人提供)：芝加哥大学肿瘤学K12项目的总体目标是培养下一代高技能的学术肿瘤学家，他们能够设计和管理假设驱动的试点/第一阶段、第二阶段和第三阶段癌症治疗试验和观察性研究。为了做到这一点，我们在学术上严格的培训环境中创建了一个严密的结构和指导的教育计划，为学术肿瘤学的职业生涯准备最有吸引力的申请者。该计划以我们的综合癌症中心为基础，由医学博士Olufunmilayo Olopade和医学博士Everett Vokes领导，并得到执行委员会以及内部和外部咨询委员会的大力支持。保罗卡拉布雷西K12学者计划是我们的高度指导，授课密集的课程，并“动手”临床研究培训，其结果是在健康研究/临床研究的理学硕士学位。利用整个大学的资源，我们在翻译科学方面创建了一套综合的跨学科课程，融合了基因组学、社会科学、基于社区的、临床和生物信息学以及人口研究。在其第一个资助周期中，该计划成功招聘了5名内科肿瘤学家、2名外科肿瘤学家和4名博士科学家，他们获得了在团队研究环境中进行以患者为中心的癌症治疗研究所需的广泛研究培训和全面经验，并将他们的研究努力集中在以患者为中心的研究上。与我们学院的所有培训项目一样，保罗·卡拉布雷西学者项目的一个明确目标是，它的培训机会和好处将远远超出它将提供津贴的相对较少的学者。该计划已经产生了变革性和全球性的影响，并正在接触到芝加哥更大的“全球”肿瘤学实习生社区，以及来自其他国家的年轻肿瘤学家，他们作为全球健康学者来到我们研究所接受培训。因此，从该计划的实施中获得的好处是巨大的。

 DESCRIPTION (provided by applicant): The overall goal of the University of Chicago K12 program in Oncology is to produce the next generation of highly skilled academic Oncologists who are capable of designing and administering hypothesis-driven pilot/Phase I, Phase II and Phase III cancer therapeutic trials and observational studies. To do this, we have created a tightly structured and mentored education program within an academically rigorous training environment that prepares the most compelling applicants for careers in academic oncology. The program is anchored within our Comprehensive Cancer Center and led by Olufunmilayo Olopade, MD along with Everett Vokes, MD with strong support from an Executive Committee as well as Internal and External Advisory Committees. The Paul Calabresi K12 Scholars Program is our highly mentored, didactic coursework-intensive program, and "hands on" clinical research training which results in a Master of Science in Health Studies/Clinical Investigations. Leveraging resources across the University, we have created a set of integrated interdisciplinary courses in translational science that blends genomics, social sciences, community based, clinical- and bio-informatics, and population studies. In its 1st funding cycle, the program has been successful in recruiting 5 Medical Oncologists, 2 Surgical Oncologists and 4 PhD Scientists who obtain the broad research training and comprehensive experience necessary to conduct patient-oriented cancer therapeutic research in team research environments, and to focus their research endeavors on patient-oriented research. An explicit goal of this Paul Calabresi Scholars program, as with all training programs in our institution, is that its training opportunities and benefits will extend far beyond the relatively few scholars whose stipends it will provide. The program has had a transformative and global impact and is reaching into the larger "global" oncology trainee community in Chicago and to young oncologists from other countries who come to train at our Institution as Global Health Scholars. Thus, the benefit that accrues from the program's implementation is substantial.